About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Synthetic CBD as a Therapy for COVID-19 | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 1NCT04686539

Synthetic CBD as a Therapy for COVID-19

The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compa...

Lead sponsor: Sheba Medical Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Howard Amital, MD, MHA

CONTACT

+972-3-5302638 Howard.Amital@sheba.health.gov.il

Sponsors

Lead Sponsor

Sheba Medical Center

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•COVID 19 patients
•18 Years and older

Exclusion Criteria

•Respiratory failure requiring mechanical ventilation
•Intensive care unit admission
•Neutrophile con. \< 1000 cells/mm3
•Lymphocyte con \< 500 cells/mm3
•Liver enzymes 5 times higher then the norm
•QT interval longer then 500 ms.
•Pregnancy
•Hemodialysis renal replacement therapy
•Active or prior psychotic event

Related studies

RECRUITINGPhase 2

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

NCT07189936 · Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more

Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)

NCT01668186 · Peroxisome Biogenesis Disorder, Zellweger Spectrum Disorder, and more

The Effect of the Covid-19 Pandemic Among Operated Patients

NCT04525716 · Covid19, Surgery

RECRUITINGPhase 3

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

NCT03188796 · Critical Illness, Vitamin D Deficiency, and more

COVID-19 Survivorship Registry

NCT04527315 · Covid19

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 28, 2021Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE1

Enrollment50

Start dateJan 2021

Last updatedSep 28, 2021

Condition

Locations shown

Sheba Medical Center, Tel Hashomer

Ramat Gan, Tel Aviv

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 28, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions